Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
Journal of Pediatric Gastroenterology and Nutrition|January 16, 2020
Micronutrients, Metabolic Complications, and Inflammation in Ugandan Children With HIVSahera Dirajlal-Fargo, Lingpeng Shan, Abdus Sattar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2022
Longitudinal Changes in Subclinical Vascular Disease in Ugandan Youth With Human Immunodeficiency VirusSahera Dirajlal-Fargo, Chenya Zhao, Danielle Labbato, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1Adele L McCormick, Chris M Parry, Anne Crombe, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2008
Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidityBarbara Suligoi, Stefano Buttò, Claudio Galli, et al.
Tropical Medicine & International Health : TM & IH|November 25, 2010
Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DARTPaula Munderi, Wendy B Snowden, Ann Sarah Walker, et al.
Antiviral Therapy|October 26, 2011
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in AfricaWolfgang Stöhr, Andrew Reid, A Sarah Walker, et al.
AIDS Research and Treatment|March 29, 2012
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan AdultsMohammed Lamorde, Pauline Byakika-Kibwika, William S Tamale, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
Pageof 20